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Background: Visceral fat accumulation is one of the most important predictors of mortality in obese populations.
Administration of green tea extract (GTE) can reduce body fat and reduce the risk of obesity-related diseases in
mammals. In this study, we investigated the effects and mechanisms of GTE on adiposity in diet-induced obese
(DIO) zebrafish.
Methods: Zebrafish at 3.5 to 4.5 months post-fertilization were allocated to four groups: non-DIO, DIO,
DIO + 0.0025%GTE, and DIO + 0.0050%GTE. The non-DIO group was fed freshly hatched Artemia once daily (5 mg
cysts/fish daily) for 40 days. Zebrafish in the three DIO groups were fed freshly hatched Artemia three times daily
(60 mg cysts/fish daily). Zebrafish in the DIO + 0.0025%GTE and DIO + 0.0050%GTE groups were exposed to GTE
after the start of feeding three times daily for 40 days.
Results: Three-dimensional microcomputed tomography analysis showed that GTE exposure significantly decreased
the volume of visceral but not subcutaneous fat tissue in DIO zebrafish. GTE exposure increased hepatic expression
of the lipid catabolism genes ACOX1 (acyl-coenzyme A oxidase 1, palmitoyl), ACADM (acyl-coenzyme A dehydrogenase,
c-4 to c-12 straight chain), and PPARA (peroxisome proliferator-activated receptor alpha). GTE exposure also
significantly decreased the visceral fat expression of SOCS3 (suppressor of cytokine signaling 3b) which inhibits leptin
signaling.
Conclusions: The present results are consistent with those seen in mammals treated with GTE, supporting the
validity of studying the effects of GTE in DIO zebrafish. Our results suggest that GTE exerts beneficial effects on
adiposity, possibly by altering the expression of lipid catabolism genes and SOCS3.
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ZebrafishBackground
According to 2005 World Health Organization estimates,
approximately 1.6 billion adults worldwide were over-
weight (body mass index [BMI]≥ 25 kg/m2) and at least
400 million were obese (BMI≥ 30 kg/m2), and these num-
bers are expected to reach 2.3 billion and 700 million,* Correspondence: tanaka@doc.medic.mie-u.ac.jp
2Department of Molecular and Cellular Pharmacology, Pharmacogenomics
and Pharmacoinformatics, Mie University Graduate School of Medicine, 2-174
Edobashi, Tsu, Mie 514-8507, Japan
3Department of Bioinformatics, Mie University Life Science Research Center,
2-174 Edobashi, Tsu, Mie 514-8507, Japan
Full list of author information is available at the end of the article
© 2012 Hasumura et al.; licensee BioMed Cen
Commons Attribution License (http://creativec
reproduction in any medium, provided the orrespectively, by 2015 [1]. It is widely accepted that obesity
results from a positive energy balance [2]. In general,
obesity can be classified into visceral and subcutaneous
types according to the distribution of fat. Visceral obesity
accompanies or precedes components of the metabolic
syndrome, such as hyperinsulinemia and insulin resistance
[3]. Consequently, visceral fat accumulation is an inde-
pendent predictor of mortality in men [4].
Green tea, one of the most popular beverages in Asian
countries, contains numerous polyphenols known as cate-
chins, particularly epigallocatechin gallate, epicatechin
gallate, and gallocatechin gallate. Tea and tea componentstral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Hasumura et al. Nutrition & Metabolism 2012, 9:73 Page 2 of 7
http://www.nutritionandmetabolism.com/content/9/1/73have many beneficial properties, including antioxidant [5],
anticancer [6,7], antidiabetic [8], and anti-atherogenic [9]
activities. Moreover, intake of tea catechins inhibits diet-
induced obesity (DIO) in mice [10,11] and reduces body
weight and body fat in humans [12-17]. These anti-obesity
effects of tea catechins seem to involve stimulation of fat
oxidation [10,18,19], modulation of adipogenesis [20],
decreased fat synthesis [6,20-22], and inhibition of digest-
ive enzyme activity and nutrient absorption [8].
Zebrafish (Danio rerio) are vertebrates, and their organs
and tissues show similarities to those of humans in terms
of their structure and function. Consequently, zebrafish
are increasingly being used as models of human diseases
[12,23-25] because of their ease of genetic manipulation
and their economic potential for use in breeding and test-
ing. In addition, lipid metabolism in zebrafish is very simi-
lar to that in humans in terms of intestinal absorption
with the aid of bile produced in the liver [26], transport of
fat and cholesterol by lipoproteins [27], β-oxidation [28],
and storage as triacylglycerols in visceral, subcutaneous,
and intramuscular adipocyte depots [26,29]. Because of
these similarities and advantages, zebrafish are used in
lipid metabolism research as a model for lipid-related dis-
eases, including atherosclerosis induced by high-cholesterol
diets [30] and obesity induced by overexpression of the en-
dogenous melanocortin antagonist agouti-related protein
(AgRP) [29]. Moreover, Oka et al. demonstrated the useful-
ness of a zebrafish model of DIO that shares common
pathophysiological pathways with mammalian obesity [31].
DIO zebrafish have also been used to validate the anti-
obesity effects of natural products [32].
Here, we investigated the effects of green tea extract
(GTE) on body weight, visceral and subcutaneous fat ac-
cumulation, and the expression of lipid metabolism
genes in the liver and visceral fat in DIO zebrafish.
Methods
Ethical approval
This study conformed to the ethical guidelines estab-
lished by the Institutional Animal Care and Use Com-
mittee of Mie University.
GTE
GTE was prepared and analyzed as previously described
[33]. In brief, green tea leaves (Camellia sinensis) were
soaked in hot water and the resulting extract was
reduced to a powder by spray drying. The extract was
then dissolved in hot water and mixed with an equal vol-
ume of chloroform. The aqueous phase was recovered
with three volumes of ethanol and the extract was
freeze-dried after removing the solvent. The composition
of catechins was measured by high-performance liquid
chromatography. The total catechin content in the GTE
was 79.6%–81.8% (w/w, the sum of all catechins); thiscomprised epigallocatechin gallate (43.6%–44.4%), epigallo-
catechin (20.4%–20.7%), epicatechin gallate (12.0%–12.3%),
epicatechin (8.1%–8.3%), gallocatechin (6.9%–7.0%), gallo-
catechin gallate (4.4%), and others (3.7%–3.8%). The caf-
feine content was 0%–0.1%.
Animals
Male and female zebrafish (AB strain, the Zebrafish
International Resource Center, Eugene, OR, USA) were
kept at approximately 28°C under a 14-h light and 10-h
dark cycle. Water conditions of environmental quality
were maintained according to The Zebrafish Book [34].
Experimental design
Experiment 1
Male and female zebrafish at 3.5–4.5 months post-
fertilization were allocated to four groups (non-DIO,
DIO, DIO+ 0.0025%GTE, and DIO+ 0.0050%GTE) with
five fish per 1.7-L tank. Zebrafish in the non-DIO (con-
trol group) were fed freshly hatched Artemia for
120 min once a day (5 mg cysts/fish daily) for 40 days.
Zebrafish in the three DIO groups were fed freshly
hatched Artemia for 120 min three times daily (60 mg
cysts/fish daily). Zebrafish in the DIO+ 0.0025%GTE
and DIO+ 0.0050%GTE groups were exposed to GTE
for 105 min, starting 15 min after the start of feeding
(total exposure, 315 min/day), three times daily for
40 days. During feeding, the tank water flow was
stopped; the water in each tank was replaced with fresh
water at the end of feeding. Body weight was measured
on days 0, 14, 20, 27, 34, and 40. Body fat volume was
measured using three-dimensional microcomputed tom-
ography (3D micro-CT) following euthanasia on the
final day of the study.
Experiment 2
Female zebrafish were allocated to three groups (non-
DIO, DIO, and DIO+ 0.0050%GTE) with five fish per
1.7-L tank. All groups were fed as described in Experi-
ment 1 for 21 days. After feeding on the final day, the
zebrafish were euthanized, immediately transferred into
tubes containing 8 mL of RNAlater (Qiagen, Valencia,
CA, USA), and stored at 4°C until gene expression
analysis.
CT measurement of body fat volume
Zebrafish were fixed in a stretched position on a sample
holder. The 3D micro-CT scan was performed with an
in vivo System R_mCT 3D micro-CT scanner (Rigaku
Corporation, Tokyo, Japan). The following settings were
used: voltage, 90 kV; current, 100 μA; magnification, ×4;
slice thickness (scanning width), 50 μm; and exposure
time, 2 min. Images were reconstructed and viewed
using i-View type R software (J. Morita Mfg., Kyoto,
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using CTAtlas Metabolic Analysis Ver. 2.03 software
(Rigaku Corporation). The Hounsfield unit (HU) value
of fat tissue was adjusted to between –350.0 and –145.0
in accordance with the manufacturer’s instructions.
Measurement of body fat volume was limited to the ab-
dominal cavity, and the initial point of the abdominal
cavity was set at the cleithrum (Figure 1A). Body fat was
then divided into visceral fat and subcutaneous fat along
the ribs (Figure 1B).
RNA extraction and quantitative real-time PCR
The liver and visceral fat were dissected from the stored
fish samples prepared in Experiment 2 and were sub-
jected to RNA extraction. Total RNA was extracted from
the livers of fish in all three groups (non-DIO, DIO, and
DIO+ 0.0050%GTE) using Isogen (Nippongene, Tokyo,
Japan) with combination with cleanup protocol of
RNeasy mini kit (Qiagen K.K., Tokyo, Japan). cDNA was
synthesized using random primers and SuperScript III
Reverse Transcriptase (Invitrogen, Carlsbad, CA, USA).
Total RNA was extracted from the visceral fat of fish in
the DIO and DIO+ 0.0050%GTE groups using an
RNeasy Lipid tissue mini kit (Qiagen) and qualified
using an Agilent Bioanalyzer 2100 (Agilent, Santa Clara,
CA, USA). Because of poor RNA quality, the samples




Figure 1 Cross-sectional images taken by three-dimensional
micro-computed tomography. The diagram of the zebrafish shows
where the two cross-sectional images A and B were taken. (A) The
red two-headed arrow shows the area where body fat volume was
measured (yellow). (B) The green line shows the boundary between
the visceral fat and the subcutaneous fat (orange). The light green
area indicates body fat outside the measuring area. The white arrow
indicates the cleithrum.cDNA was synthesized using a High Capacity RNA-to-
cDNA Kit (Applied Biosystems, Foster City, CA, USA).
Total RNA could not be extracted from the visceral fat
of fish in the non-DIO group because the amount of vis-
ceral fat was too small.
Quantitative real-time PCR was performed on cDNA
samples using a TaqMan Fast Universal PCR Master Mix
(Applied Biosystems) or Fast SYBR Green Master Mix (Ap-
plied Biosystems) and an ABI Prism 7500 Fast Real-Time
PCR System (Applied Biosystems) in accordance with the
manufacturer’s instructions. The TaqMan gene expression
assays were as follows: PPIA (peptidylprolyl isomerase Aa;
Dr03152038_m1), ACOX1 (acyl-coenzyme A oxidase 1,
palmitoyl; Dr03147239_m1), ACADM (Dr03120754_m1),
PPARA (peroxisome proliferator-activated receptor alpha b;
Dr03149883_m1), and SOCS3 (suppressor of cytokine sig-
naling 3b; Dr03203997_s1). The primer sets for SYBR
Green were as follows: ACC (acetyl-CoA carboxylase gene,
XM_678989, forward primer (5′–3′): ATCATCCCACC
CAAACAGAC; reverse primer (3′–5′): CCCATCACA
GAAGGTGGAAC) and FASN (fatty acid synthase gene,
XM_682295, forward primer (5′–3′): ATCTGTTCCTGTT
CGATGGC, reverse primer (3′–5′): AGCATATCTCGGC
TGACGTT). The baseline and threshold were set manually
in accordance with the manufacturer’s instructions. The
relative mRNA expression levels were determined using
PPIA as an endogenous standard.
Feeding volume assay
The feeding volume assay was conducted as previously
described [32], with minor modifications, on day 39 of
Experiment 1. Briefly, hatched Artemia (5 or 60 mg
cysts/fish/day) were fed to the zebrafish in a 1.7-L tank
as described above. For a blank control, Artemia were
placed in a 1.7-L tank without zebrafish (the tank con-
tained water alone). After 90 min, the number of Arte-
mia not eaten by the zebrafish were counted three times
and subtracted from the number in the blank tank to de-
termine the feeding volume in each tank.
Statistical analysis
All values are presented as means ± standard error of
the mean. Statistical analysis was conducted using ana-
lysis of variance followed by Fisher’s partial least-squares
difference multiple comparison test. Analyses were con-
ducted using STATVIEW for Windows version 5.0 (SAS




Visual observation revealed no marked abnormalities
or major differences in feeding behavior between the
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Figure 2 Effects of green tea extract (GTE) on body weight.
Changes in body weight in male (M) and female (F) zebrafish. Values
are means ± SE. **P< 0.01 and *P< 0.05 vs. the diet-induced obese
(DIO) group.
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the amount of Artemia provided (consumption ratio) was
estimated in the feeding volume assay. In male zebrafish,
the consumption ratio in the DIO+0.0025%GTE (40%)
and DIO+0.0050%GTE (37%) did not decrease compared
with that in the DIO group (24%). And also in female, the
consumption ratio in the DIO+0.0025%GTE (33%) and
DIO+0.0050%GTE (38%) did not decrease compared
with that in the DIO group (33%).
Body weight
Significant increases in body weight were observed
within 14 days of the start of the experiment in male
and female zebrafish in the DIO group compared with
those in the non-DIO group (Figure 2). This trend was
maintained throughout the 40-day study. From day 14
onward, exposure to 0.0050% GTE significantly reduced
the diet-induced body weight gain in females (P < 0.05 or
P < 0.01 compared with the DIO group). By contrast,
there were no significant reductions in diet-induced
body weight gain in males exposed to either dose of
GTE, or in females exposed to 0.0025% GTE.
Body fat volume
To quantify body fat volume in DIO zebrafish, we per-
formed 3D micro-CT analysis. This allowed us to quan-
tify the total body fat volume and to separately quantify
the visceral and subcutaneous fat volumes. Figure 3
compares the body fat volumes between each experi-
mental group. Total body fat, visceral fat, and subcuta-
neous fat volumes in both sexes in the DIO group were
significantly greater than those in the non-DIO group.
Total body fat and visceral fat volumes in male DIO zeb-
rafish were significantly reduced by exposure to 0.0050%
GTE, and those in female DIO zebrafish were signifi-
cantly reduced by both doses of GTE. However, in both
sexes, there were no significant differences in subcutane-
ous fat volume between the DIO group and either GTE-
treated group.
Liver and visceral fat mRNA expression in females
We analyzed the mRNA expression levels of lipid me-
tabolism genes in the liver and visceral fat tissue of fe-
male DIO zebrafish because the suppressive effects of
GTE on body fat accumulation were greater in females
than in males.
In the liver on day 21 of the experiment, the mRNA
expression levels of the mRNAs encoding ACOX1 (a
peroxisomal β-oxidation enzyme), ACADM (a mito-
chondrial β-oxidation enzyme), and PPARA (a nuclear
receptor protein that regulates β-oxidation) were signifi-
cantly upregulated in the DIO+0.0050%GTE group
compared with the DIO group (Figure 4). By contrast,
there was no significant difference in the mRNAexpression of SOCS3 (a protein that suppresses leptin
signaling).
In the visceral fat on day 21 of the experiment, the
mRNA expression levels of ACOX1, ACADM, and PPARA
in the DIO+0.0050%GTE group were not significantly
differ from those in the DIO group. In addition, there
were no significant differences in the mRNA expression
levels of FASN (fatty acid synthase) or ACC (acetyl-CoA
carboxylase), which play important roles in lipogenesis.
On the other hand, the mRNA expression of SOCS3 was
significantly lower in the DIO+0.0050%GTE group than
in the DIO group (Figure 5).
Discussion
In this study, we demonstrated that GTE significantly sup-
pressed the accumulation of visceral fat, but not subcuta-




















































Figure 3 Effects of green tea extract (GTE) on body fat volume.
Mean body fat volume in male (M) and female (F) zebrafish after
40 days of feeding. Values are means ± SE. ***P< 0.001, **P< 0.01,




























Figure 4 Effects of green tea extract (GTE) on the expression of
lipid metabolism genes in the liver. ACOX1, ACADM, PPARA, and
SOCS3 mRNA expression in the liver of female zebrafish on day 21 of
feeding. The expression of each mRNA was normalized against PPIA
mRNA expression and the corresponding expression in the diet-
induced obese (DIO) group. Values are means ± SE. **P< 0.01 and

























Figure 5 Effects of green tea extract (GTE) on the expression of
lipid metabolism genes in visceral fat. ACOX1, ACADM, PPARA,
FASN, ACC, and SOCS3 mRNA expression in the visceral fat of female
zebrafish on day 21 of feeding. The expression of each mRNA was
normalized against PPIA mRNA expression and the corresponding
expression in the diet-induced obese (DIO) group. Values are means ±
SE. *P<0.05 vs. the DIO group.
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sion of lipid catabolism genes. These results are very con-
sistent with the findings of previous studies in humans
[12,14] and rodents [10,11,13,14,35-37]. Although it is un-
clear whether the functions of visceral and subcutaneous
fat in zebrafish are homologous to those in mammals,
our findings indicate that body fat distribution is
present in zebrafish as well as in humans and animals
and that the site-specific effects of GTE are similar to those
in mammals.
The mechanisms underlying the suppressive effects of
GTE on body fat accumulation have been investigated in
rodent models. Some studies have shown that upregu-
lated PPARs and many lipid-metabolizing enzymes
stimulate fat oxidation in the liver [11,35,36]. The hep-
atic gene expression pattern observed in DIO zebrafish
in our study support these earlier findings. Although itwas recently reported that the expression of lipogenic
genes, such as FASN, is downregulated in visceral fat tis-
sue in obese mice [38], similar changes were not
observed in our study. We assume that the reason for
this discrepancy is the difference in obesity models used.
In particular, Park et al. used obese mutant mice with
increased FASN gene expression in adipose tissue [38],
whereas we used a wild-type strain of fish. In support of
the hypothesis that the activities of FASN differs be-
tween models of obesity, Letexier et al. reported that
adipose tissue FASN expression is not affected by a
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obese humans [39]. Their results help support the no-
tion that adipose tissue gene expression profiles differ
among species, and the lack of consistency between our
data and those of Park et al. Nevertheless, our present
results suggest that the mechanism by which GTE sup-
presses body fat accumulation, at least in the liver, in
zebrafish is similar to that in rodents.
We also found that GTE significantly decreased the
expression of SOCS3 in the visceral fat of DIO zebrafish.
SOCS3 is a negative regulator of leptin signaling and
was recently proposed as an important therapeutic target
for obesity [40]. SOCS3 production in fat is associated
with obesity in humans and rodents as SOCS3 gene ex-
pression is increased in subcutaneous fat of obese
patients [41], and its protein and gene expression levels
are increased in epididymal fat of DIO rodents [42,43].
We found that GTE suppressed adipose tissue SOCS3
expression in zebrafish, which was accompanied by
reduced body fat accumulation. To our knowledge, these
results suggest for the first time that SOCS3 expression
is correlated with body fat volume in zebrafish and is
involved in the regulation of body fat volume by GTE.
Another valuable outcome of this study is that 3D
micro-CT analysis can be used to analyze the effect of
compounds on adiposity in DIO zebrafish. In humans,
visceral fat accumulation, unlike subcutaneous fat accu-
mulation, is strongly associated with metabolic and vas-
cular risks, particularly diabetes, hypertension, and
stroke, and thus increases the risk of mortality [3]. CT is
widely used to measure body fat volume in humans
[44,45] and in rodents [46,47]. Although CT is used to
evaluate fillet composition in teleosts, such as salmon
and carp [48-50], to our knowledge, no reports have
used CT to measure body fat volume or visceral/
subcutaneous fat volume in small teleosts. Our data
raise the possibility that micro-CT could be used to
measure body fat volume in such fish. We believe
this technique will play an important role in future
studies of lipid metabolism and obesity in zebrafish.
Conclusions
We showed that GTE significantly inhibits weight gain
and body fat accumulation, and alters the expression of
hepatic lipid catabolism genes in DIO zebrafish. Our
results suggest that GTE exerts beneficial effects on adi-
posity, possibly by altering the expression of lipid catab-
olism genes and SOCS3.
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